Showing results (111-120 of 339) with videos related to

Sort By:
Pageof 34
Stroke Research and Treatment|August 12, 2010
Intracranial vertebrobasilar artery dissection associated with postpartum angiopathyJames S McKinney, Steven R Messé, Bryan A Pukenas, et al.
Stroke|October 28, 2006
The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic strokeDavid M Kent, Harry P Selker, Robin Ruthazer, et al.
Circulation. Cardiovascular Quality and Outcomes|January 16, 2014
Using internally developed risk models to assess heterogeneity in treatment effects in clinical trialsJames F Burke, Rodney A Hayward, Jason P Nelson, et al.
Structural Heart : the Journal of the Heart Team|September 9, 2020
Can Clinical Predictive Models Identify Patients Who Should Not Receive TAVR? A Systematic ReviewBenjamin S Wessler, Andrew R Weintraub, James E Udelson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 31, 2017
Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life ExpectancyDavid van Klaveren, John B Wong, David M Kent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2003
Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agendaDavid M Kent, Donnie McGrath, John P A Ioannidis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2010
Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysisIssa J Dahabreh, Georgios D Kitsios, David M Kent, et al.
Journal of Clinical Epidemiology|November 15, 2017
The proposed 'concordance-statistic for benefit' provided a useful metric when modeling heterogeneous treatment effectsDavid van Klaveren, Ewout W Steyerberg, Patrick W Serruys, et al.
The American Journal of Medicine|December 29, 2017
Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk ModelJenica N Upshaw, David van Klaveren, Marvin A Konstam, et al.
Stroke|October 28, 2006
Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3- to 6-hour time window?David M Kent, Harry P Selker, Robin Ruthazer, et al.
Pageof 34